Whether ATP/ADO accumulation in the extracellular milieu will prove beneficial or detrimental for the host will depend on (i) the concentration of ATP as a result of release from cells; (ii) the rate of degradation of ATP to ADO by ectonucleotidases and (iii) the panel of receptors expressed by tumor and infiltrating inflammatory cells. This evidence concerns the gene ADO and neoplasm.